About this trial
The Comprehensive Care of Sleep Disordered Breathing study (Care-SDB) is a prospective, multi-center, registry-based cohort study designed to investigate the integrated management of sleep-disordered breathing (SDB). The investigators aim to establish a nationwide SDB cohort and biobank to identify prognostic biomarkers, explore pathogenic mechanisms, and evaluate optimal treatment models. A total of 11,100 adult patients with recent sleep monitoring will be enrolled and followed longitudinally for up to 5 years. Data collection, including clinical outcomes and major adverse events, will be managed via a unified Electronic Data Capture platform. The results from Care-SDB are expected to provide critical evidence-based guidance for the risk stratification, standardized intervention, and personalized management of patients with sleep-disordered breathing.
Eligibility criteria
Qualifiers
Age ≥ 18 years.
Patients who have completed sleep breathing monitoring within 1 month prior to enrollment.
Capable of providing signed informed consent.
Disqualifiers
Estimated life expectancy of less than 3 months.
Refusal to participate in the study.
Inability to cooperate with baseline data collection or follow-up evaluations.
Trial design
Treatments tested in this trial
- Clinical Management for SDB
Treatment groups
Sponsors and collaborators
Beijing Anzhen Hospital
Lead sponsor
Beijing Hospital
Collaborator
Second Xiangya Hospital of Central South University
Collaborator
Peking University Hospital of Stomatology
Collaborator
Shantou University Medical College
Collaborator
Shanghai Institute of Hypertension
Collaborator
First Affiliated Hospital of Fujian Medical University
Collaborator
Beijing Tiantan Hospital
Collaborator
Beijing Jishuitan Hospital
Collaborator
Beijing Friendship Hospital
Collaborator
West China Hospital
Collaborator
Beijing Chao Yang Hospital
Collaborator